Oregon recalls

B. Braun Medical Inc is recalling certain 21-gauge winged infusion needles used to expand tissue expanders. The needle tips may be dull, blunt, or break during use, which could make the device difficult or impossible to use properly.

B. Braun's 21G winged injection needles used for tissue expander procedures may have dull, blunt, or broken needle tips. This can make the needle difficult to advance during use. The issue affects specific lot numbers with expiration dates through September 2032.

Staar Surgical EVO+ Visian Toric Implantable Collamer Lenses (Model VTICM5) were labeled as 12.1 mm but are actually 12.6 mm in length. The larger size can cause the lens to sit too high in the eye, potentially reducing eye drainage and increasing eye pressure, which may lead to discomfort, vision problems, or the need for lens removal.

The Olympus ShockPulse-SE Lithotripsy System generator (model SPL-G) may fail to recognize its transducer and remain in a blinking waiting state. This can happen if the transducer plug or generator receptacle becomes damaged. The device is used in medical settings to break up kidney stones and similar calculi.

The Olympus ShockPulse-SE Lithotripsy System, used to break up kidney stones and similar calculi, may experience problems where the generator remains in a blinking phase and fails to recognize the transducer. This can happen if the transducer plug or generator receptacle becomes damaged. No injuries have been reported.

Olympus Corporation is recalling ShockPulse-SE Lithotripsy Systems (Model SPL-SR) because the generator may get stuck in a blinking state and fail to recognize the reusable probe. This can happen if the probe plug or generator connection becomes damaged. The device is used in hospitals and medical facilities to break up kidney stones and similar calculi.

Roche Diagnostics' cobas pro automated laboratory analyzer has a software defect that can cause it to accept incorrect calibrations. When this happens, the machine repeats the same result for multiple patient and quality-control tests instead of calculating new values, potentially leading to inaccurate lab results. This affects specific blood tests including ferritin, vancomycin, and light chain measurements.

GE Healthcare has identified a software issue in certain versions of its Centricity Universal Viewer Zero Footprint Client where patient information displayed in the viewer may not match the medical images being shown. This could occur in specific workflows on systems with Patient Timeline installed. The issue affects approximately 250 units.

The differential pressure sensor in some Abiomed Impella RP heart pump devices may malfunction, causing inaccurate sensor readings. This affects 179 units distributed worldwide. No injuries have been reported to date.

The differential pressure sensor in some Abiomed Impella RP Flex with SmartAssist heart pump devices may malfunction, causing inaccurate sensor readings. This is a Class I recall affecting approximately 4,496 devices distributed worldwide. No injuries have been reported to date.

The differential pressure sensor in certain Abiomed Impella RP heart pump devices may malfunction and provide inaccurate readings. This could affect the device's ability to monitor and respond appropriately during use. About 291 devices worldwide are affected.

Mylan Pharmaceuticals is recalling specific lots of Amnesteem (isotretinoin) 40 mg capsules because they failed to meet dissolution specifications—meaning the medication may not break down and be absorbed by your body as intended. This could affect how well the medicine works. The recall affects two lots (3116110 and 3116130) with an expiration date of July 2026.

MR. 7 SUPER 700000 capsules contain hidden prescription drugs—sildenafil and tadalafil—that are not listed on the label. These are serious medications that can interact with other drugs and cause health problems. The product was sold without FDA approval.

Mojo Max Fusion XXX capsules contain hidden prescription drugs—sildenafil and tadalafil—that were not listed on the label. These are potent medications that can cause serious health problems, especially if you take other drugs or have certain heart or blood pressure conditions. The FDA has not approved this product for sale.

Radnostix Sodium Iodide (I-131) Solution, a prescription oral therapeutic medication, is being recalled because some vials contain particulate matter due to production issues. The affected medication is in 1 ml, 2 ml, and 3 ml vials with batch number I012626R-01 and expiration date 02/09/2026. No injuries have been reported.

SILINTAN 25 pills, sold in 25-count bottles, contain an undeclared ingredient called meloxicam, a prescription pain reliever. The FDA found this ingredient was not listed on the label and the product was not approved by the FDA. The recall affects all lots currently in use.

HTO Nevada Inc. (doing business as Kirkman) is recalling one lot of Maximum Zone 2 4% Lidocaine Cream because stability testing does not support the printed expiration date. The product may lose strength or safety before the labeled date.

Kirkman's Maximum Zone 1 4% Lidocaine Cream (1/2 oz bottles) is being recalled because stability testing does not support the listed expiration date of July 31, 2026. This means the product may not maintain its intended strength and safety beyond an earlier date. The recall affects lot #807CP-0003 distributed nationwide.

Kirkman's FIVE-STAR VASOCAINE Spray (a local anesthetic spray) is being recalled because the manufacturer's stability testing does not support the printed expiration dates on the bottles. This means the product may degrade or become less effective before the labeled date. Nine lots distributed nationwide are affected, with expiration dates ranging from March 2026 to July 2028.

Rising Pharmaceuticals is recalling specific bottles of Temozolomide 5mg capsules because testing found the medication didn't meet quality standards for purity and stability. The issue was discovered during routine 9-month stability testing. This affects 1,200 bottles distributed nationwide with expiration date 09/2026.

Major Pharmaceuticals is recalling midodrine hydrochloride 5 mg tablets (Lot N02640, expiring 08/2027) because some blister packages are not properly sealed. Defective packaging could allow the medication to degrade or become contaminated. No injuries have been reported.

Cipla USA is recalling Nilotinib 200 mg capsules (Lot 5GJ0223, expiring 04/30/2027) because the capsules failed quality tests during stability testing. The capsules may not meet appearance and description standards, which means their safety and effectiveness cannot be guaranteed.

Cipla USA is recalling specific lots of Nilotinib 150 mg capsules because testing found the capsules did not meet appearance and description standards after six months of storage. The affected lots are 5GJ0220, 5GJ0221, and 5GJ0222, with expiration date 04/30/2027. No injuries have been reported.

The FDA is recalling semaglutide powder distributed by Harbin Jixianglong Biotech for compounding use only. The manufacturer did not complete required manufacturing process and bacterial endotoxin testing before shipping the product. This was a manufacturing oversight, not a confirmed safety incident.

Harbin Jixianglong Biotech distributed semaglutide (an injectable medication for compounding) without completing required manufacturing process and bacterial endotoxin testing. This means the drug may not meet safety and purity standards. The affected lot is CP-030-20250711 with an expiration date of July 24, 2027.

ACME United Corporation's antimicrobial alcohol hand wipes (70% isopropyl alcohol) are being recalled because the manufacturer did not follow proper quality and safety procedures during production. Multiple lot numbers with expiration dates ranging from April 2027 to January 2028 are affected. No injuries have been reported.

The FDA identified manufacturing quality deviations (CGMP violations) in three lots of Children's Healthcare of Atlanta instant hand sanitizing wipes. These wipes may not meet quality and safety standards. The affected lots were distributed nationwide.

Dynarex BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%) in 1000-packet boxes were manufactured with deviations from FDA quality standards. Affected lots are 53518 and 53519, with expiration dates of June 2027. The products were distributed nationwide.

Dynarex BZK Antiseptic Towelettes have been recalled because the manufacturer did not follow required quality and safety standards during production. The FDA identified manufacturing practice deviations that could affect product safety or effectiveness. No injuries have been reported.

Green Guard Antiseptic Wipes have been recalled due to manufacturing quality control issues. The FDA found that these wipes did not meet proper manufacturing standards. This affects specific lots distributed nationwide.